Vaccines for adults EO 14398
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 75D30126D20935
- Awardee
-
Glaxosmithkline, LLC UEI FRHTPHMZMX47
- Awarding agency
-
CDC Pittsburgh
Centers for Disease Control and Prevention, Department of Health and Human Services
- Task orders
- 0
Award facts
- Opportunity
-
- Vaccines for Adults FY26-27 Solicitation · 75D30126R73406 · Posted Mar 24, 2026
- Last date to order 30% complete
- IDV ceiling
- $88,196,470.00
- Maximum order
- $88,196,470.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 6 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Centers for Disease Control and Prevention Pittsburgh awarded an indefinite-delivery contract to Glaxosmithkline, LLC with a ceiling of $88,196,470 on July 1, 2026. This is a multiple-award vehicle with no set-aside.
Place of performance for vaccine delivery is the CDC's centralized distribution centers located in Olive Branch, Mississippi, and Clermont, Kentucky, with administration handled by the CDC Office of Acquisition Services in Chamblee, Georgia.
The solicitation, posted March 24, 2026, sought procurement of 17 standard commercial adult vaccine types under the Section 317 immunization program for persons aged 19 and older, including Hepatitis A and B, Human Papillomavirus, Herpes Zoster, Meningococcal, Measles/Mumps/Rubella, Pneumococcal, Tetanus/Diphtheria/Pertussis, Varicella, RSV, MPOX, and E-IPV vaccines. Offerors were required to demonstrate FDA licensure, 12-month minimum shelf life, Federal Excise Tax credit compliance, EDI capability to interface with the CDC's Vaccine Tracking System, and capacity to deliver within 15 working days of order receipt. Evaluation criteria were equally weighted across technical merit, price, and past performance.
The contract runs from July 1, 2026, through June 30, 2027. Minimum order sizes are 100 doses per vaccine type (10 doses for Varicella), with maximum quantities established per product.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $5,079,797 | |
| Original award | $5,291,941 |
Quick answers
Who was awarded contract 75D30126D20935?
75D30126D20935 was awarded to Glaxosmithkline, LLC by CDC Pittsburgh (Centers for Disease Control and Prevention) on July 1, 2026.
How much is contract 75D30126D20935 worth?
75D30126D20935's own ceiling is $88,196,470. A single order can be worth up to $88,196,470.
Who can order from contract 75D30126D20935?
75D30126D20935 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75D30126D20935 competed?
The extent of competition for 75D30126D20935 was full and open competition. The government received 6 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV